Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open‐label randomized comparative pilot clinical study

Psoriasis is commonly treated with topical corticosteroids, oral cytotoxic drugs and biologic agents, which can be associated with significant adverse effects (AEs), high cost and response attenuation. Additionally, patients often use alternative therapies ad hoc, which can be challenging to integra...

Descripción completa

Detalles Bibliográficos
Autores principales: Alex, P., Williams, S., Sutton, L., Yesudas, T., Sutton, C., Thomas, S., Centola, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Concise Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154690/
https://www.ncbi.nlm.nih.gov/pubmed/31419323
http://dx.doi.org/10.1111/ced.14074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154690/
https://www.ncbi.nlm.nih.gov/pubmed/31419323
http://dx.doi.org/10.1111/ced.14074

Ejemplares similares